Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 6, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Adipose-derived stem cells for myocardial infarction.

Manuel Mazo1, Juan José Gavira, Beatriz Pelacho

  • 1Hematology and Cell Therapy and Foundation for Applied Medical Research, Division of Cancer, University of Navarra, Av. Pío XII 36, Pamplona, Spain.

Journal of Cardiovascular Translational Research
|December 1, 2010
PubMed
Summary

Adipose-derived stem cells show promise for treating myocardial infarction due to their accessibility and regenerative potential. This review explores their mechanisms for cardiac repair and therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple myeloma: A tale of deregulated transcription factors.

HemaSphere·2026
Same author

Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response.

Nature communications·2026
Same author

IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

Blood·2026
Same author

Deacetylase inhibitors CM-444 and CM-1758 enhance chemotherapy response in AML via ALOX5.

British journal of haematology·2026
Same author

Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma.

Blood neoplasia·2026
Same author

Genetically driven immune microenvironment states associate with therapeutic responses in MYD88 mutant lymphomas.

Molecular cancer·2026

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Biology

Background:

  • Myocardial infarction (MI) necessitates innovative treatments.
  • Adipose tissue is a rich source of stem cells for regenerative therapies.
  • Stem cells from adipose tissue offer potential for treating various diseases, including cardiovascular conditions.

Purpose of the Study:

  • To review the use of adipose-derived stem cells (ADSCs) for myocardial infarction treatment.
  • To examine the in vivo mechanisms of action for ADSCs in cardiac repair.

Main Methods:

  • Review of current scientific literature on ADSCs and MI.
  • Analysis of differentiation capacity and paracrine activity of ADSCs.
  • Investigation of proposed in vivo mechanisms of action.

More Related Videos

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
08:03

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Related Experiment Videos

Last Updated: Jun 6, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
08:03

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Main Results:

  • ADSCs are accessible and efficient to harvest.
  • ADSCs possess differentiation and paracrine capabilities.
  • ADSCs are candidates for treating immunological and cardiovascular diseases.

Conclusions:

  • Adipose-derived stem cells are a promising therapeutic option for myocardial infarction.
  • Further research into ADSC mechanisms is crucial for optimizing cardiac regenerative therapies.